Does IPILIMUMAB Cause Metastases to central nervous system? 233 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 233 reports of Metastases to central nervous system have been filed in association with IPILIMUMAB (YERVOY). This represents 0.6% of all adverse event reports for IPILIMUMAB.
233
Reports of Metastases to central nervous system with IPILIMUMAB
0.6%
of all IPILIMUMAB reports
55
Deaths
118
Hospitalizations
How Dangerous Is Metastases to central nervous system From IPILIMUMAB?
Of the 233 reports, 55 (23.6%) resulted in death, 118 (50.6%) required hospitalization, and 18 (7.7%) were considered life-threatening.
Is Metastases to central nervous system Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for IPILIMUMAB. However, 233 reports have been filed with the FAERS database.
What Other Side Effects Does IPILIMUMAB Cause?
Death (3,710)
Malignant neoplasm progression (3,296)
Diarrhoea (2,557)
Off label use (2,097)
Colitis (1,988)
Pyrexia (1,796)
Rash (1,556)
Fatigue (1,447)
Intentional product use issue (1,329)
Nausea (1,169)
What Other Drugs Cause Metastases to central nervous system?
TRASTUZUMAB (1,180)
CAPECITABINE (663)
OSIMERTINIB (560)
PERTUZUMAB (540)
PACLITAXEL (498)
NIVOLUMAB (495)
DABRAFENIB (451)
CARBOPLATIN (413)
DOCETAXEL (410)
ADO-TRASTUZUMAB EMTANSINE (386)
Which IPILIMUMAB Alternatives Have Lower Metastases to central nervous system Risk?
IPILIMUMAB vs IPRAGLIFLOZIN L-PROLINE
IPILIMUMAB vs IPRATROPIUM
IPILIMUMAB vs IPRATROPIUM\IPRATROPIUM ANHYDROUS
IPILIMUMAB vs IPTACOPAN
IPILIMUMAB vs IRBESARTAN